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Ayurveda has an outstanding role towards achieving 
the ‘Right To Sight’ of every individual. The branch of 
‘Shalakya Tantra’ is one among Ashtanga Ayurveda, 
which specializes in the treatment of ‘Jatrurdhwagata 
rogas’.  
‘Jatrurdhwa Pradesha’, which is considered the 
‘Uttamanga’,   harbours   all    the   five   sense   organs  
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(jnanendriyas). Among these, ‘Netra’ (Eye) is of 
utmost importance and the quotation 
‘Sarvendriyanam  Nayanam  Pradhanam’ perfectly 
substantiates it. 
“Vision” the ability to see, perceive, interpret, and 
enjoy the surroundings is one of the greatest assets a 
human being is blessed with. The joys and sorrows of 
a man, his state of health and disease, all are reflected 
in his eyes. Hence eyes can be regarded as the main 
link between man and his environment. Hence, it’s 
aptly said “Eyes are the index of man’s mind and 
nature”. 
The importance of eyes and vision is clearly depicted 
by Acharya Vaghbhata in ‘Ashtanga Hridayam’ (A. H. 
Uttarasthana 13/98) as: One must take keen interest 
in protecting one’s eyes and vision all through his life.  
Day and night seem to be the same for a blind man. 
Though endowed with all the wealth in the world he 
will still be considered a poor man, for having been 
deprived from the wealth of light.
[1]
 Blurred or 
A B S T R A C T  
Keratonus is one of the important causes of progressive myopia and its incidence is 1 in 500 
worldwide. Keratoconus is a degenerative disorder of the eye in which structural changes within the 
cornea cause it to thin and change to a more conical shape than the more normal gradual curve. 
Keratoconus typically starts at puberty as a progressive myopia causing substantial distortion of vision 
and marked astigmatism rapidly. This results in significant visual impairment leading to problems in 
doing routine works like driving and reading. Only temporary measures like Contact lenses and 
Surgery are available. In Ayurvedic terms, it can be correlated with Prathama Patalagata Timira. As 
Tarpana is considered to be supreme among all the Kriyakalpas in treating timira, it has been selected 
for the study. Giving due importance to the doshas and the site of pathology involved, Jeevantyadi 
Ghrita and Mahatriphaladi Ghrita are selected. Hence a clinical study has been done to compare the 
efficacies of Mahatriphaladi ghrita tarpana and Jeevantyadi Ghrita tarpana in Keratoconus.   
Key words: Keratoconus,  Mahatriphaladi ghrita,  Jeevantyadi ghrita, Tarpana. 
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defective vision is one of the commonly faced 
problems nowadays and the cause of this can be 
majorly attributed to ‘refractive errors’.  
The disease ‘Keratoconus’ is an important cause of 
‘Curvatural Progressive Myopia’. Keratoconus is 
defined as a corneal disorder in which there is a 
progressive thinning of the central part leading to 
conical protrusion and there by uncorrected visual 
error, usually found in second or third decade.
[2]
  
The contemporary science advocates power glasses, 
contact lenses, corneal implants, corneal collagen 
cross linking with riboflavin (C3R), Laser assisted 
surgeries and keratoplasty in treating the keratoconus 
disease. These measures can temporarily combat the 
symptoms but no complete cure is available. Blurred 
vision or Avyakta Darshana or timira is mentioned as a 
symptom in 12 drushtigata vikaras, when there is 
doshic vitiation involving the prathamapatala of the 
eye. 
Timira further leads to Kacha and Linganasha as its 
complication. So it is better to intervene at the initial 
phase to arrest the progression of the condition, 
which may even lead to blindness. ‘Brumhana’ line of 
treatment can be best adopted considering Vatadosha 
Vruddhi in the pathology and Krishna mandala 
(Cornea) being formed by Vatadosha.Tarpana is one 
of the best ‘Netrakriyakalpa’ for brumhana purpose 
i.e. to nourish the eyes and to cure the vata-pittaja 
diseases. In addition, the Snehana, Chakshushya and 
Vata-pittahara action of the medicated ghee may be 
very much useful in the management of Keratoconus. 
OBJECTIVES OF THE STUDY 
1. To evaluate the efficacy of Tarpana with 
Mahatriphaladi Ghrita in Keratoconus 
2. To evaluate the efficacy of Tarpana with 
Jeevantyadi Ghrita in keratoconus 
3. To compare the results obtained in 2 groups  
4. To understand keratoconus disease in Ayurvedic 
perspective 
MATERIALS AND METHODS 
Source of data 
The patients who were clinically diagnosed as 
keratokonus were randomly selected from the OPD 
and IPD of Shri Jayachamarajendra  Institute of 
Medical College, Bangalore.  
Methodology 
40 patients presenting with the clinical features of 
Keratoconus were randomly selected and divided into 
2 groups of 20 patients each. Totally 69 eyes were 
affected among  40 patients. 
Group A is treated with Jeevantyadi ghrita tarpana for 
5 days. Same procedure was repeated with a gap of 7 
days for 4 sittings.  
Group B is treated with Mahatriphaladi ghrita tarpana 
for 5 days and the procedure is repeated with a gap of 
7 days for 4 sittings. 
Both groups were assessed after a period of one 
month after completion of treatment. Patients were 
followed for 3 months. 
Table 1: 





Tarpana for 5 days with a gap 





Tarpana for 5 days with a gap 
of 7 days for 4 sittings 
Method of preparation 
Jeevantyadi Ghrita as per the classical method 
explained in Astanga Hridaya (A. H. Uttaratantra 13/2-
3) and Mahatriphaladi Ghrita as per the classical 
method explained in Bhaishajya Ratnavali (B. R. 
64/249-256) were prepared as in Rasashastra and 
Bhaishajya Kalpana practical hall. 
Procedure 
Prior to the Tarpana proper, Seka using warm Triphala 
quatha is performed as poorva karma.  
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Later a wall is constructed around the eyes at a height 
of 2 angulas and the luke warm Jeevantyadi Ghrita is 
poured into it, and retained for 700 matra kaala (Sa. 
Sam. U. 13/45-47). Later it is taken off through the 
hole created at the lower end of lateral side of the 
wall. As a paschat karma, Jatimukula are placed over 
the eye and Bandhana is done to prevent the 
exposure of eyes to bright light. 
Criteria of Assessment  
The results were assessed based on the relief found in 
the signs and symptoms of the disease.  For accessing, 
the main clinical signs and symptoms were graded 
based on the severity as mild, moderate and severe. 
Before treatment (BT) is the severity of the signs and 
symptoms before starting the treatment. After 
treatment (AT) is the severity of the signs and 
symptoms on 30
th
 day after completion of four sittings 
of the scheduled therapy. 
Statistical Analysis of the Result 
Analysis of the result is determined by the values 
obtained before and after the treatment in both the 
groups, and is calculated by using Paired ‘t’ test. The 
results are considered as significant only if the P value 
is ‘< 0.05’ in this study. 
RESULTS 
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The result after statistical analysis suggests that Group 
A showed 67% whereas Group B showed 64% of 
overall result. During follow-up, there was 11% and 14 
% of recurrence seen in the symptoms in Group A and 
Group B consecutively. 
DISCUSSION 
Majority of the patients in the study were male (55%). 
Though there is no much evidence about 
predominance of keratoconus in males, both sexes 
are considered equally affected according to various 
studies. This observation might be due to professional 
compulsion of getting the condition treated in male 
population. 
Around 67% patients had chronicity of more than 2 
years. The reason might be the failed approach of 
treatment in contemporary medicine. 
Only 20% of patients had a family history of similar 
complaints. The reason is increasing exposure of 
younger generation to heat, UV radiations and 
gadgets; hence hereditary history need not be there 
though the disease has a tendency for hereditary 
transmission to next generation. 
Highest percentages i.e. 73% of the patients were in 
between the age group of 15 to 25years. This 
observation upholds the typical occurrence of the 
disease in adolescent young age. 
Maximum patients were associated with ‘Vernal 
Kerato-Conjunctivitis’ (VKC) (36%). This observation 
might be due to the age related association of VKC. 
Cornea is the first refractive media for the light rays to 
enter the eyeball. When the protruded and thinned 
out cornea scatters the entering light rays, there will 
be distorted image formed. The involvement of 
Vatadosha mainly is obvious in this pathology. 
Tarpana is a nourishing and oleating procedure, which 
acts exactly opposite to Vata and Pitta doshas, 
involved in the disease. 
Tarpana forms an occlusive film over the surface of 
the eyeball and improves the composition of tear film 
by enhancing the mucin and aqueous layers. It 
prevents frictional damage to the ocular surfaces 
secondary to lid movement or extra ocular 
movements. It acts by retaining fluid and maintaining 
hydration of the ocular surface.  
The Ghrita has the quality of trespassing into minutest 
channels of the body. Absorption is very high as drugs 
are lipid soluble penetration is high irrespective of 
molecular size. In the description of the Drishti, 
Sushruta has mentioned that Sheeta dravyas are 
Satmya (wholesome) for Drishti. Ghrita also has 
Sheetavirya, hence the eye being the site of ‘Alochaka 
pitta’ can be effectively managed by constantly using 
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Ghee for Akshi Tarpana. Ghrita also possess 
properties like Balya, Brimhana and Rasayana, so it 
gives strength to the overall tissues of the eyeball as 
well as to the nervous tissues. 
Jeevantyadi Ghrita has high levels of antioxidants
[3]
 
which can reduce the oxidative stress and damage of 
thinned out cornea.
[4]
 Ghrita is one among the best 
Rasayana drugs and Jivanti is one among the best 
Chakshushya drugs, and most of the contents of 
Jeevantyadi Ghrita have Tridosha pacifying action. So 
Jivantyadi Ghrita having all the properties was 
selected for the study. 
Mahatriphaladi Ghrita, indicated in Timira, has the 
ingredients like triphala, shatavari, guduchi, 
ajaksheera, draksha, yashtimadhu, ksheera kakoli, 
madhuparni, nidigdhika, neelotpala, pippali and 
goghrita.
[6]
 Most of the drugs have ‘Madhura Rasa’, 
‘Sheeta Veerya’, ‘Madhura Vipaka’ and are 
‘Chakshushya’. Majority contain antioxidants, which 
reduce the free radicals that cause oxidative damage 
to the eye.  
Avyaktadarshana, the main symptom of ‘timira’ was 
found to be have significant improvement with P 
value <0.0001 in both the groups. This can be justified 
by Vata-pittahara property of the ingredients of 
Jeevantyadi Ghrita
[4] 
and Mahatriphaladi Ghrita. 
Foreign body sensation can be explained as caused by 
follicles and papillary reaction caused by dryness. 
There was significant improvement in both the groups 
with p value < 0.0001. Tarpana increases corneal and 
conjunctival hydration levels and this might be the 
reason for improvement. 
Headache and eyestrain are the asthenopic symptoms 
due to high degree of irregular astigmatism in 
Keratoconus. There was significant improvement in 
both the groups with p value < 0.0001. The basic 
cause of these symptoms is the increasing conicity of 
cornea. Tarpana is believed to have pressure effect 
over the cornea, thus shaping the extended conicity. 
There has been highly significant improvement in 
these symptoms in both the groups. 
Ghosting is a symptom where the person finds clear 
image in one eye and multiple or spread image in the 
effected eye. The improvement found with p value < 
0.0001 in group A and 0.0002 in group B, can be 
explained by the favorable changes in the protruded 
and thinned out cornea by Tarpana. 
Night vision defect was moderately improved in both 
the groups. Group A showed better results than group 
B with p value 0.0004. This improvement can be 
understood by the changes caused by Tarpana in the 
curvature defect and thickness. The Chakshushya 
properties of the drugs is also a significant reason 
behind the improvement of vision. 
Itching and watering are due to irritation caused by 
dryness and exposure of corneal nerves respectively. 
The vata-pittahara property of the drugs can be the 
reason behind the significant improvement observed. 
The significant changes in cylindrical power indicates 
positive changes in the corneal curvature i.e. 
increased thickness. The attributes to the Vata-
pittahara and brimhana properties of the drugs. 
Blurred vision, Eyestrain and Itching have shown 
highly significant difference between two groups. The 
reason behind this might be properties of the 
individual Ghritas. Jevantyadi Ghrita tackles eyestrain 
much better than Mahatriphaladi Ghrita. Whereas 
Blurred vision and itching is much more reduced with 
Mahatriphaladi ghrita tarpana because of presence of 
more Chakshushya dravyas and Kaphahara dravyas. 
CONCLUSION 
Keratoconus can be understood as 
Prathamapatalagata Timira based on the literature 
and observation. The historical analysis of the effect 
of Vatahara line of treatment also supports the 
involvement of Vata in Keartoconus. The demographic 
observations are supporting the incidence of age,
[7]
 
association with VKC and Dry eyes and family history. 
The drugs selected for the study was dosha-
pratyaneeka i.e. vata-pittahara in nature. The 
treatment plan was found effective in improving the 
corneal thickness and overall symptoms in both the 
groups. But Jeevantyadi Ghrita Tarpana yielded 
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slightly better results than with Mahatriphaladi Ghrita 
Tarpana. No patients had any adverse effects during 
the course of the trial. The contemporary measures 
like spectacles and surgery are in effective in treating 
Keratoconus permanently. Classical ‘Ayurvedic Eye 
therapies’, when studied in a larger population and 
standardized as a best Alternative solution for such 
sight threatening diseases, it can serve to protect the 
“Right to sight” of every individual. 
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